10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prevalence of Helicobacter pylori Infection in Patients with Chronic Kidney Disease

      editorial
      Gut and Liver
      Editorial Office of Gut and Liver

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          There have been some debates about the association of Helicobacter pylori infection and chronic kidney disease (CKD). Pathogenesis of H. pylori infection in patients with CKD is not clearly revealed and there are not enough studies about these two factors. There are several hypothesis which support that kidney disease may reduce H. pylori infection. High level of serum urea nitrogen can contribute to a decreased gastric acid secretion and higher gastric pH which could be the cause of lower prevalence of H. pylori among CKD.1 Inflammatory cytokines are also increased in CKD patients and it can cause gastric mucosal damage, chronic gastritis, and spontaneously eradicate H. pylori.2 In addition, antibiotics, proton pump inhibitors, or H2 receptor antagonists which are used in patients with CKD for long time might be associated with decreased H. pylori infection.3 There are other hypothesis that are contrary to above theories. Some studies showed that high urea concentration makes the gastric mucosa more susceptible to H. pylori and infection rate is higher in uremic patients.4,5 And, in some articles which have studied about peptic ulcer in CKD, the prevalence of H. pylori infection looked lower compare to ulcer in non-CKD patients but real incidence may not be lower.6 Because the incidence of peptic ulcer is higher in CKD patients with various causes except H. pylori infection.7 In nationwide study of Taiwan, H. pylori infection rate is lower in peptic ulcer disease patients with CKD and end-stage renal disease (ESRD) than in those without CKD.6 On the contrary, recent meta-analysis studies showed no relation between H. pylori infection and CKD nor ESRD.8,9 However, those previous meta-analysis about the association between H. pylori infection and kidney disease have some selection biases. In this research,10 authors tried to minimize bias of previous meta-analyses and showed the results about the prevalence of H. pylori infection in patients with CKD. In this issue of Gut and Liver, Shin et al.10 included many articles compared to previous studies using systematic reviews and narrowed inclusion criteria to increase the accuracy of the results. Studies with only CKD patients were enrolled and other studies which have vague inclusion criteria including renal transplant recipients, diabetic nephropathy, or pediatric population were excluded. Authors compared the prevalence of H. pylori infection between CKD patients and control first, then showed subgroup analyses according to the modifiers. In the 47 case-control or cross-sectional studies, CKD patients were 4,084 and controls without CKD were 6,908, and total prevalence of H. pylori infection in CKD patients was 48.2% and in controls was 59.3%. Pooled analysis using 34 studies with same study design and statistical models supported significantly lower rate of H. pylori infection in CKD patients (odd ratio, 0.64; 95% confidential interval, 0.52 to 0.79). This meta-analysis10 showed lower infection rate of H. pylori in CKD patient with or without dialysis compare to non-CKD patients. Based on this research, there are some interesting points and further considerations. In this study, subgroup analysis showed the different results according to the methodological quality of included studies and significantly lower prevalence rate of H. pylori infection in CKD patients compare to controls was revealed in high qualified studies. In previous study which reported negative association of H. pylori with CKD,8 author showed trend of decreased risk of H. pylori infection in patients with CKD in subgroup which had lower heterogeneity. These factors can be thought that, if studies can be focused to the adult CKD patients without renal transplant recipient or diabetes mellitus nephropathy, the prevalence of H. pylori infection may be clearly lower in CKD patients. This kind of clear result could pave the way for researchers to focus on the next step such as to clarify the reason of decreasing H. pylori infection in CKD patients. This study, which was performed using statistical techniques of great effort, has important clinical meaning because authors found that H. pylori infection rate is lower in CKD patients compare to non-CKD patients. And they gave a message of importance about the well-designed study. Based on these results, further studies are expected to clearly the association between H. pylori and renal function and finally to contribute reducing the H. pylori infection.

          Related collections

          Most cited references10

          • Record: found
          • Abstract: found
          • Article: not found

          Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: a 2-year study.

          The role of Helicobacter pylori in the pathogenesis of peptic ulcer disease in patients with uraemia remains unclear. To evaluate the long-term effect of H. pylori eradication in these patients. Uraemic and non-uraemic patients with peptic ulcer were enrolled in this study. Patients having history of non-steroidal anti-inflammatory drugs use or cardiovascular disease that need aspirin use were excluded. After confirmation of H. pylori infection, they received a triple therapy and were followed up for 2 years. Between September 1999 and December 2005, 34 patients (41%) of the end-stage renal disease [H. pylori (+) group] and 67 (84%) of the non-uraemic patients with peptic ulcer disease (PU group) received anti-H. pylori therapy. After triple therapy, 32 (94%) from the end-stage renal disease group and 64 (96%) from the peptic ulcer group obtained successful eradication. During the 2-year follow-up, three patients in the end-stage renal disease group were excluded because of the presence of cardiovascular disease and aspirin use in two cases and died of heart failure in one case; two patients in peptic ulcer group refused follow-up. Finally, 29 uraemic and 62 non-uraemic patients had achieved the follow-up. Recurrence of peptic ulcer was more in the end-stage renal disease group than in the peptic ulcer group with intention-to-treat analysis (eight of 32, 25% vs. two of 64, 3%, P = 0.001, OR: 10.0, 95% CI: 1.979-50.540) or per-protocol analysis (eight of 29, 28% vs. two of 62, 3%, P < 0.001, OR: 11.4, 95% CI: 2.245-58.168). Peptic ulcer recurrence after H. pylori eradication is higher in end-stage renal disease patients with peptic ulcer than in peptic ulcer patients without renal disease. Factors aside from H. pylori play an important role in peptic ulcer recurrence in end-stage renal disease patients.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            CAMPYLOBACTER PYLORIDIS, UREASE, HYDROGEN ION BACK DIFFUSION, AND GASTRIC ULCERS

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Association between Helicobacter pylori and end-stage renal disease: A meta-analysis

              AIM To investigate the prevalence and association of Helicobacter pylori (H. pylori) with end-stage renal disease (ESRD). METHODS SA comprehensive literature search was completed from inception until October 2016. Studies that reported prevalence, relative risks, odd ratios, hazard ratios or standardized incidence ratio of H. pylori among ESRD patients were included. Participants without H. pylori were used as comparators to assess the association between H. pylori infection and ESRD. Pooled risk ratios and 95%CI was calculated using a random-effect model. Adjusted point estimates from each study were combined by the generic inverse variance method of DerSimonian and Laird. RESULTS Of 4546 relevant studies, thirty-seven observational studies met all inclusion criteria. Thirty-five cross-sectional studies were included in the analyses to assess the prevalence and association of H. pylori with ESRD. The estimated prevalence of H. pylori among ESRD patients was 44% (95%CI: 40%-49%). The pooled RR of H. pylori in patients with ESRD was 0.77 (95%CI: 0.59-1.00) when compared with the patients without ESRD. Subgroup analysis showed significantly reduced risk of H. pylori in adult ESRD patients with pooled RR of 0.71 (95%CI: 0.55-0.94). The data on the risk of ESRD in patients with H. pylori were limited. Two cohort studies were included to assess the risk of ESRD in patients with H. pylori. The pooled risk RR of ESRD in patients with H. pylori was 0.61 (95%CI: 0.03-12.20). CONCLUSION The estimated prevalence of H. pylori in ESRD patients is 44%. Our meta-analysis demonstrates a decreased risk of H. pylori in adult ESRD patients.
                Bookmark

                Author and article information

                Journal
                Gut Liver
                Gut Liver
                Gut and Liver
                Editorial Office of Gut and Liver
                1976-2283
                2005-1212
                November 2019
                15 November 2019
                : 13
                : 6
                : 585-586
                Affiliations
                Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
                Author notes
                Correspondence to: Ji Yong Ahn, Department of Gastroenterology, Asan Digestive Disease Research Institute, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea, Tel: +82-2-3010-5667, Fax: +82-2-476-0824, E-mail: ji110@ 123456hanmail.net
                Author information
                https://orcid.org/0000-0002-0030-3744
                Article
                gnl-13-585
                10.5009/gnl19310
                6860031
                31724387
                e3501c6e-98e3-424c-9e81-3a8263654648
                Copyright © 2019 by The Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, Korean Pancreatobiliary Association, and Korean Society of Gastrointestinal Cancer.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                Categories
                Editorial

                Gastroenterology & Hepatology
                Gastroenterology & Hepatology

                Comments

                Comment on this article